New changes to the National Cervical Screening Program mean that anyone with a cervix, aged 25 to 74, will be able to choose to have a Cervical Screening Test either by:
Both options are:
When you opt to collect your own vaginal sample, you will be provided with a swab by your healthcare provider and instructions on how to do the test. The sample can be taken in a private space (behind a curtain or in the bathroom).
Self-collection is available any time a HPV test is needed. This includes for follow-up HPV testing after an intermediate risk result and cervical screening during pregnancy.
Source – https://www.health.gov.au/news/self-collection-now-available-for-cervical-screening
]]>More people at higher risk of severe illness from COVID-19 will be able to access life-saving oral antiviral treatments from Monday 11 July.
The prescription-only oral treatments, Paxlovid and Lagevrio, have been found to be effective in treating mild to moderate COVID-19 in adults aged 18 years of age and older, who do not require supplemental oxygen, and who are at increased risk of progressing to hospitalisation.
New eligibility includes updated age limits and risk factors.
Find out more about your risk factors and expanded eligibility.
Find out more about Paxlovid and Lagevrio.
PBAC Web Outcome Statement.
Source – https://www.health.gov.au/news/covid-19-oral-treatment-eligibility-expanded-from-11-july-2022
]]>
We are now beginning to see a new wave of COVID-19 infections, driven by the BA.4 and BA.5 Omicron subvariants. We expect that this wave will lead to a substantial increase in infections, hospitalisations and sadly, deaths, at a time when our communities and health systems are already under strain. Without increased community and public health actions, this impact may be similar to that experienced during the BA.1 wave in January this year.
BA.4 and BA.5 are associated with increased immune escape and we are likely to see rates of reinfection rise among those who have previously been infected with an earlier COVID-19 variant and those who are up to date with their vaccinations. Vaccination continues to be the most important protection against severe illness.
Given reinfections may occur as early as 28 days after recovery from a previous COVID-19 infection, the AHPPC advises that the reinfection period be reduced from 12 weeks to 28 days. People who test positive to COVID-19 more than 28 days after ending isolation due to previous infection should be reported and managed as new cases.
The AHPPC reiterates the shared responsibility of individuals, employers and governments in minimising the impact of COVID-19. There are a range of health behaviours all Australians can undertake to reduce the transmission of COVID-19, protect the community, in particular those most at risk, and protect our health system and essential services, such as:
Treatment is now available for eligible people with COVID-19. Information can be found at Oral treatments for COVID-19 or speak to your GP now to see if you are eligible for oral treatments should you become infected. Oral treatments can assist in preventing severe disease in people at higher risk.
All of these actions become important during significant waves of COVID-19. If all Australians continue to work together, through early and collective actions, the impact of the BA.4/BA.5 wave can be reduced. Now is the time for all of us to act to protect ourselves, our loved ones, the health system, those who are more at risk and the broader community.
Source – https://www.health.gov.au/news/ahppc-statement-on-covid-19-winter-update-and-ongoing-health-protection-measures-to-support-our-community